iifl-logo

HP Adhesives Ltd Directors Report

Add as a Preferred Source on Google
₹31.08
(-2.51%)
Nov 18, 2026|03:59:43 PM

HP Adhesives Ltd Share Price directors Report

Dear Members,

The Board of Directors are delighted to present the 7th Annual Report on the business and operations of HP Adhesives Limited (the Company) along with the summary of consolidated and standalone financial statements for the year ended 31st March, 2026.

In compliance with the applicable provisions of the Companies Act, 2013, (the Act), the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), this Boards Report is prepared based on the Standalone financial statements of the Company for the year under review and also presents the key highlights of performance of Subsidiary and its contribution to the overall performance of the Company for the year under review.

OVERVIEW OF FINANCIAL PERFORMANCE

Key highlights of consolidated and standalone financial performance for the year ended 31st March, 2026, are summarised as under:

( in Lakhs)
Particulars Consolidated Standalone
2025-26 2024-25 2025-26 2024-25
Revenue from operations 24,927.52 24,979.33 24,866.85 24,819.63
Other income 359.72 457.62 343.60 448.22
Total Revenue 25,287.24 25,436.95 25,210.46 25,267.86
Total Expenditure 24,468.56 23,064.11 24,404.12 22,949.36
Profit before Exceptional items and tax 818.68 2,372.84 806.33 2,318.50
Less: Exceptional items (80.98) - (80.98) -
Profit Before Tax 737.70 2,372.84 725.36 2,318.50
Tax expenses (40.00) (548.48) (37.14) (534.47)
Profit after Tax 697.70 1,824.36 688.22 1,784.03
Other Comprehensive Income for the year 16.37 (9.69) 16.37 (9.69)
Total Comprehensive Income for the year 714.07 1,814.67 704.58 1,774.34

FINANCIAL HIGHLIGHTS:

Consolidated Performance

On a consolidated basis, revenue from operations stood at 24,927.52 Lakhs as compared to 24,979.33 Lakhs in FY 2024-25. Total income was 25,287.24 Lakhs against 25,436.95 Lakhs in the previous year.

The Group reported a Profit Before Tax of 737.70 Lakhs as against 2,372.84 Lakhs in FY 2024-25. Profit After Tax for FY 2025-26 stood at 697.70 Lakhs compared to 1,824.36 Lakhs in the previous year. Earnings per Share decreased from 1.99 to 0.76 per equity share.

Primary reason for lower profitability and flat growth in revenues was due to lost sales and higher operating expenses on account of fire incident that occurred at Companys Unit I located at Survey no. 7, Hissa 14 at Narangi Village, Taluka Khalapur, District Raigad, Maharashtra. Details about this incident have been covered subsequently.

The financial results have been discussed in detail in the Management Discussion and Analysis Report which forms part of this Annual report.

Standalone Performance

During FY 2025-26, the Companys standalone revenue from operations increased marginally to 24,866.85 Lakhs as compared to 24,819.63 Lakhs in the previous financial year. Total income stood at 25,210.46 Lakhs against 25,267.86 Lakhs in FY 2024-25.

Profit Before Tax (PBT) for the year was 725.36 Lakhs as against 2,318.50 Lakhs in the previous year, while Profit After Tax (PAT) stood at 688.22 Lakhs compared to 1,784.03 Lakhs in FY 2024-25. The decline in profitability was primarily attributable to the fire incident. Earnings per Share (EPS) decreased from 1.94 to 0.75 per equity share.

FIRE INCIDENT AT THE COMPANYS FACTORY PREMISES:

A fire incident occurred at Companys manufacturing unit Unit I - situated at Survey No.7, Village Narangi, Tal. Khalapur, Dist. Raigad - 402107, Maharashtra, at approximately 7:30 PM. on Saturday, 17th January, 2026.

Fire occurred in the main packaging building undertaking Solvent cement packaging and filling activity in Unit I. This building also housed the packaging inventory as well as work in process goods alongwith most recent packed finished goods.

Production got halted at Unit I and Unit II along all product categories for few days post fire; However, Unit II production was re-initiated immediately thereafter upon receipt of necessary approvals from relevant government authorities related to Fire.

The key action that the management undertook to re-initiate Solvent cement production was to immediately order packaging lines and all other related machinery and equipments along with utilities. Necessary provisions were made in the Unit II building to set up the solvent cement production and packaging lines there (as space was available) to the extent possible and also to outsource production and packaging to select vendors to support the demand in the market.

Operating Margins got reduced as sales were lost due to fire;

Several unforeseen expenses were incurred for fire like production outsourcing, repair works, rented storage places for storing packaging material, labour expenses, etc.

Not only finished goods and raw material, but also packaging inventory was affected alongwith Building and plant and machinery;

The Company, however, has adequate cover under the Industrial All Risk (IAR) policy which is with New India Assurance Co. Ltd. and co-insured with ICICI Lombard. As on 31st March, 2026, the loss assessment is under process covering inventory, plant and machinery and equipments and Land & building (P&M and Land & building loss estimate will be on re-instantment basis). Company also has Loss of Profit cover in the IAR policy. Assessment of loss of profit will commence once production and sales will reach pre-fire levels and necessary re-instantment of affected building and plant and machinery will happen. Claim submission by Company is currently under process as on 31st March, 2026.

DIVIDEND & RESERVES

Declaration and payment of dividend

The Board is pleased to recommend a final dividend amounting to 0.40 (20%) per fully paid-up equity share of 2/- each for the financial year 2025-26.

The said dividend, if approved by the Members at the ensuing Annual General Meeting (AGM) will be paid to those Members whose names appear on the register of Members (including Beneficial Owners) of the Company as at the end of Tuesday, 15th September, 2026 and, would involve cash outflow of 3.67 Crs, resulting in a payout of 52.67% of the consolidated net profits (profit after tax) of the Company for FY 2025-26.

Record date

The record date fixed for determining the entitlement of Members for payment of dividend is Tuesday, 15th September, 2026. Pursuant to the Finance Act, 2020, as amended from time to time, dividend income is taxable in the hands of the Members and the Company is required to deduct tax at source from dividend paid to the Members at prescribed rates as per the Income Tax Act, 2025.

Transfer of Unpaid / Unclaimed dividend and shares to IEPF

Pursuant to the provisions of Section 124 of the Companies Act, 2013, dividend declared by the Company which remains unpaid or unclaimed for a period of 30 days from the date of declaration is transferred to the Unpaid Dividend Account of the Company. Members who have not encashed or claimed their dividend are requested to approach the Companys Registrar and Share Transfer Agent / the Company for obtaining payment thereof.

The details of unpaid and unclaimed dividends are available on the website of the Company. The dividend amount remaining unclaimed for a period of seven years from the date of its transfer to the Unpaid Dividend Account shall be transferred to the Investor Education and Protection Fund (IEPF) established by the Central Government, together with the corresponding shares on which dividends remain unclaimed for seven consecutive years.

The provisions of Section 125 of the Act is not applicable, as seven years have not elapsed since first dividend declaration in FY 2023-24.

TRANSFER TO RESERVES

The Board does not propose to transfer any amount to general reserves and has decided to retain the entire amount of profit for FY 2025-26 in the retained earnings.

CHANGES IN THE NATURE OF BUSINESS

During the year under review, there has been no change in the nature of business of the Company.

MATERIAL CHANGES AFFECTING THE COMPANY (AFTER CLOSURE OF FINANCIAL YEAR)

There are no material changes and commitments, affecting the financial position of the Company which has occurred between the close of the Financial Year as on 31st March, 2026, to which the Financial Statement relate and the date of this Report.

SHARE CAPITAL

Authorised, Issued, Subscribed and Paid-Up Equity Share Capital

As on 31st March, 2026 the Authorised, Issued, Subscribed and Paid-up Equity Share Capital of the Company is as follows:

Particulars No. of Shares Face Value ( \u20b9 ) Total Share Capital ( \u20b9 )
Authorised 10,00,00,000 2.00 20,00,00,000.00
Issued, Subscribed and Paid-up 9,18,74,735 2.00 18,37,49,470.00
Utilisation Of IPO Proceeds

Pursuant to Regulation 32 of the Listing Regulations, a statement/explanation for the deviation(s) or variation(s) in the use of proceeds of IPO is herein given below:

Particulars of Issue Shares Issued Amount Raised Deviation(s) or Variation(s) in the use of proceeds of issue, if any

IPO 45,97,200 Equity Shares, out of which 41,40,000 Equity Shares were in the fresh issue and the balance 4,57,200 Equity Shares was an offer for sale by Mrs. Anjana Haresh Motwani, Promoter of the Company. Out of the IPO Proceeds of ?‚? 12,596.33 Lakhs, proceeds to the Company through fresh issue of shares was ?‚? 11,343.60 Lakhs and Net proceeds after IPO expenses was ?‚? 9,669.12 Lakhs. - There were no instances of deviation(s) or variation(s) in the utilisation of proceeds as stated in the objects in respect of the IPO issue of the Company.

*Necessary disclosures have been made to the Stock Exchanges in the Statement of Deviation/Variation Report issued quarterly along with the Financial Statements.

The proceeds of IPO were utilised for the objects as disclosed in the Prospectus. Details as on 31st March, 2026 are as follows:

( ?‚? in Lakhs)

Sr. No. Object Original Amount proposed to be utilised as per the offer document Revised Amount proposed to be utilised Amount utilised* Amount Unutilised
1. Funding capital expenditure for the Proposed Expansion *2,550.90 2,550.90 2,550.90 0.00
2. Funding the incremental working capital requirements of our Company 5,400.00 5,400.00 5,400.00 0.00
3. General corporate purposes 1,723.50 1,718.20 1,718.20 0.00
Total 9,674.40 9,669.10 9,669.10 0.00
*The amount utilised represents actual payments made inclusive of taxes.

*The amount has been utilised for the Capex Object as defined in the Prospectus. However, there has been a delay in utilisation of the Capex amount as compared to revised timeline.

Details of delay in implementation of the object(s) are mentioned hereunder:

There has been no deviation in the utilisation of the IPO proceeds of the Company. The Monitoring Agency Reports are available on the Company website www.hpadhesives.com as well as submitted to stock exchanges.

DEPOSITS

During the year under review, the Company has not accepted any fixed deposits within the meaning of Section 73 of the Act and the rules made there under.

HOLDING, SUBSIDIARIES, ASSOCIATE COMPANIES AND JOINT VENTURES

The Company has only one subsidiary - Unitybond Solutions Private Limited; there are no Associate Companies or Joint Ventures.

A statement providing details of performance and salient features of the financial statement of subsidiary, associate, joint venture companies, as per Section 129(3) of the Act, is provided as Annexure A to the consolidated audited financial statement and therefore not repeated in this Report to avoid duplication.

The audited financial statements including the consolidated financial statement of the Company and all other documents required to be attached thereto are available on the Companys website and can be accessed at https://www.hpadhesives.com/investor-relations/. The financial statements of the subsidiaries are available on the Companys website and can be accessed at https://www.hpadhesives.com/investor-relations/. The Policy for determining Material Subsidiaries is available on the Companys website and can be accessed at https://www.hpadhesives.com/wp-content/uploads/2026/08/Policy-for-Determining-Material-Subsidiary.pdf.

During the year under review, the Company had no material subsidiary as per the Listing Regulations.

Consolidated Financial Statements

According to Section 129(3) of the Act, the consolidated financial statements of the Company and its Subsidiary is prepared in accordance with the relevant Indian Accounting Standard specified under the Act, and the rules thereunder form part of this Annual Report. A statement containing the salient features of the financial statements of the Companys subsidiary in Form No. AOC-1 as "Annexure I" is provided in this Annual Report.

Further, pursuant to the provisions of Section 136 of the Act, the financial statements along with other relevant documents, in respect of subsidiaries, are available on the Companys website at www.hpadhesives.com.

The details of the business of operating subsidiary during FY 2025-26 are given in the Management Discussion and Analysis Report, which forms part of this Annual Report.

DIRECTORS AND KEY MANAGERIAL PERSONNEL

The constitution of the Board of the Company is in accordance with Section 149(6) of the Act and Regulation 17 of the SEBI Listing Regulations. The detailed composition of the Board as of 31st March, 2026 is as follows:

Sr. No. Name of the Director Designation

1 Mrs. Anjana Haresh Motwani Chairperson & Executive Director

2 Mr. Karan Haresh Motwani Managing Director

3 Ms. Nidhi Haresh Motwani Executive Director

4 Mr. Surendra Kumar Mehta Independent Director

5 Mr. Rajendra Kumar Jain Independent Director

6 Mr. Ajeet Ananta Walavalkar Independent Director (Till 12th February, 2026)

7 Dr. Chandra Sekhar Nettem Independent Director (W.e.f. 12th February, 2026)

None of the Directors on the Board are disqualified under the provisions of the Act.

In terms of the requirement of the SEBI Listing Regulations, the Board has identified core skills, expertise, and competencies of the Directors in the context of the Companys businesses for effective functioning. The list of key skills, expertise and core competencies of the Board of Directors is detailed in the Corporate Governance Report.

In the opinion of the Board, all the Directors, including the Directors re-appointed during the year under review possess the requisite qualifications, experience & expertise and hold high standards of integrity.

RETIREMENT BY ROTATION

Ms. Nidhi Haresh Motwani, Executive Director of the Company, is liable to retire by rotation and being eligible for re-appointment at the ensuing Annual General Meeting ("AGM") of your Company, has offered herself for re-appointment. Her details as required under the SEBI Listing Regulations are contained in the accompanying Notice convening the ensuing AGM of your Company.

An appropriate resolution seeking your approval for her re-appointment as Director is included in the Notice.

INDEPENDENT DIRECTORS DECLARATION

In terms of Section 149 of the Act and the SEBI Listing Regulations, Mr. Surendra Kumar Mehta, Mr. Rajendra Kumar Jain, Mr. Ajeet Anant Walavalkar (till 12th February, 2026) and Dr. Chandra Sekhar Nettem (w.e.f. 12th February, 2026) are the Independent Directors of the Company as on date of this Report.

During the financial year 2025-26, Mr. Ajeet Anant Walavalkar (DIN: 09226644) ceased to be an Independent Director of the Company pursuant to his resignation from the Board with effect from 12th February, 2026 due to his health conditions. Necessary filings were done with the Stock Exchanges as required under Regulation 30 of SEBI (LODR) along with a confirmation from Mr. Walavalkar that there were no other material reasons other than those provided.

Consequent to the above resignation, Dr. Chandra Sekhar Nettem (DIN: 10646814) was appointed as Non-Executive - Independent Director of the Company with effect from 12th February, 2026, subject to the approval of the members, through Postal Ballot.

The Board places on record its appreciation for the valuable contribution and guidance provided by Mr. Ajeet Anant Walavalkar during his tenure on the Board and welcomes Dr. Chandra Sekhar Nettem to the Board.

All the Independent Directors of the Company have submitted declarations that each of them meets the criteria of independence as provided in Section 149(6) of the Act along with Rules framed thereunder and Regulation 16(1) (b) of SEBI Listing Regulations and they continue to comply with the Code of Conduct laid down under Schedule IV to the Act. In terms of Regulation 25(8) of SEBI Listing Regulations, the Independent Directors have confirmed that they are not aware of any circumstance or situation that exists or may be reasonably anticipated that could impair or impact their ability to discharge their duties with an objective independent judgment and without any external influence. The Directors have further confirmed that they are not debarred from holding the office of the director under any SEBI Order or any other such authority.

Further, in terms of Section 150 of the Act read with Rule 6 of the Companies (Appointment and Qualification of Directors) Rules, 2014, as amended, Independent Directors of the Company have included their names in the data bank of Independent Directors maintained with the Indian Institute of Corporate Affairs, in terms of Section 150 read with Rule 6 of the Companies (Appointment and Qualification of Directors) Rules, 2014.

In the opinion of the Board, the Independent Directors possess the requisite expertise and experience and are persons of high integrity and repute. They fulfill the conditions specified in the Act as well as the Rules made thereunder and are independent of the Management.

KEY MANAGEMENT PERSONNEL

In terms of Section 203 of the Act, the Key Managerial Personnel (KMP) of the Company as on 31st March, 2026 are as follows:

Mr. Karan Haresh Motwani, Managing Director

Mr. Mihir Suresh Shah, Chief Financial Officer

Ms. Swati Talgaonkar, Company Secretary and Compliance Officer (w.e.f. 24th September, 2025).

Mrs. Jyoti Nikunj Chawda has resigned from the post of Company Secretary & Compliance Officer w.e.f. 9th August, 2025.

BOARD AND COMMITTEE MEETINGS

The Board meetings are convened regularly to review and determine the Companys business policies and strategies, alongside other key governance matters. It maintains robust operational oversight with quarterly meetings featuring comprehensive presentations. Board and Committee meetings are re-scheduled in advance and informed to Directors, enabling them to plan their schedules effectively and participate meaningfully in discussions. Only in case of special and urgent business matters, if the need arises, Boards or Committees approval is taken by passing resolutions through circulation or by calling the Board / Committee meetings at a shorter notice, in accordance with the applicable law.

The agenda for the Board and Committee meetings includes detailed notes on the items to be discussed to enable the Directors to make an informed decision.

Your Board of Directors met 6 (Six) times during the FY 2025-26. The details of the meetings and the attendance of the Directors are mentioned in the Corporate Governance Report. The intervening gap between meetings were not more than 120 days as required under the Act and SEBI Listing Regulations.

The Board of Directors of your Company have formed various Committees, as per the provisions of the Act and SEBI Listing Regulations and as a part of the best corporate governance practices, the terms of reference and the constitution of these Committees are in compliance with the applicable laws and to ensure focused attention on business and for better governance and accountability. The constituted Committees are as below:

a) Audit Committee;

b) Nomination and Remuneration Committee;

c) Stakeholders Relationship Committee; and

d) Corporate Social Responsibility Committee.

The details with respect to the composition, terms of reference, number of meetings held and business transacted by the aforesaid Committees are given in the Corporate Governance Report of the Company which is presented in a separate section and forms a part of the Annual Report of the Company.

POLICY ON DIRECTORS APPOINTMENT, REMUNERATION AND OTHER DETAILS

Based on the recommendation of the Nomination and Remuneration Committee (NRC), the Board has adopted the Remuneration Policy for Directors, KMPs and Senior Management Personnel. NRC has formulated the criteria for determining the qualifications, positive attributes and independence of an Independent Director. The Companys Policy on Directors appointment, remuneration and other matters provided in Section 178(3) of the Act is disclosed in the Corporate Governance Report, which is a part of the Annual Report and is also available on https://www.hpadhesives.com/wp-content/uploads/2014/08/Nomination-and-Remuneration-Policy.pdf

BOARD EVALUATION AND ASSESSMENT

The annual evaluation process of the Board, Individual Directors and Committees was conducted in accordance with the provision of the Act and the SEBI Listing Regulations. The Board evaluated its performance after seeking inputs from all the Directors on the basis of criteria such as the Board composition and structure, effectiveness of Board processes, information and functioning, etc.

The Board and the NRC reviewed the performance of individual Directors on the basis of criteria such as the contribution of the individual Director to the Board and Committee Meetings like preparedness on the issues to be discussed, meaningful and constructive contribution and inputs in meetings, etc.

In a separate meeting of independent directors, performance of Non-Independent Directors and the Board as a whole was evaluated. Additionally, they also evaluated the performance of Chairman of the Board, taking into account the views of Executive and Non-Executive Directors in the aforesaid Meeting. The Board also assessed the quality, quantity and timeliness of flow of information between the Company Management and the Board that is necessary for the Board to effectively and reasonably perform their duties. The above evaluations were then discussed in the Board Meeting and performance evaluation of Independent directors was done by the entire Board, excluding the Independent Directors being evaluated.

FAMILIARISATION PROGRAMME

In compliance with the requirements of the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has in place a Familiarisation Programme for its Independent Directors to familiarise them with the Company, their roles, rights and responsibilities, the nature of the industry in which the Company operates, business model, strategic plans, operations, regulatory environment and risk management framework.

The Independent Directors are provided with relevant documents, reports, internal policies, business and financial updates, presentations and regulatory developments from time to time to enable them to understand the Companys business and operations. The Directors are also updated on changes in applicable laws, regulations and governance practices through presentations and discussions at Board and Committee Meetings.

During the financial year, the Independent Directors were apprised of the Companys operational performance, financial performance, business strategies, industry developments, risk management practices, internal control systems and statutory and regulatory updates.

The details of Familiarisation Program imparted to the Independent Directors for the FY 2025-26 are available on the website of the Company at https://www.hpadhesives.com/wp-content/uploads/2026/05/Details-of-familiarization-programme-FY-2025-26.pdf.

DIRECTORS RESPONSIBILITY STATEMENT

Pursuant to Section 134(5) of the Act, the Board of Directors, to the best of their knowledge and ability, confirm that:

i. in preparation of the annual accounts for the year ended 31st March, 2026, the applicable accounting standards have been followed and there are no material departures from the same;

ii. they have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of state of affairs of the Company as at 31st March, 2026 and of the profit of the Company for the year ended on that day;

iii. they have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting frauds and other irregularities;

iv. the Annual Accounts for the year ended 31st March, 2026 have been prepared on a "going concern" basis;

v. they have laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and were operating effectively throughout the financial year ended 31st March, 2026; and

vi. they have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems are adequate and operating effectively throughout the financial year ended 31st March, 2026.

Further, there are no qualifications, reservations or adverse remarks made by the statutory auditor/secretarial auditor in their respective reports.

BUSINESS RESPONSIBILITY REPORT

The provision of Regulation 34(2)(f) of the SEBI Listing Regulations, regarding the Business Responsibility Report is not applicable to the Company.

MANAGEMENT DISCUSSION AND ANALYSIS REPORT

Pursuant to Regulation 34 of the SEBI Listing Regulations, a separate section on Management Discussion and Analysis Report which also covers the consolidated operations reflecting the global nature of our business forms in integral part of the Integrated Annual Report.

CORPORATE GOVERNANCE REPORT

Pursuant to Regulation 34 read with Schedule V of the SEBI Listing Regulations, a separate section on the Corporate Governance Report, forms an integral part of the Annual Report. A certificate from Practicing Company Secretary confirming compliance with corporate governance norms, as stipulated under the SEBI Listing Regulations, is annexed to the Corporate Governance Report.

AUDITORS AND AUDITORS REPORT:

Statutory Auditor:

M/s. Priya Choudhary & Associates LLP, Chartered Accountant (Firm Registration No. 011506C/C400307), were re-appointed as the Statutory Auditors of the Company for a tenure of 5 years commencing from the conclusion of the 6th AGM of the Company until the conclusion of the 11th AGM of the Company to be held in the year 2030-31.

The Auditors Report on the financial statements of the Company for the financial year ended 31st March, 2026 forms part of the Annual Report. The said report was issued by the Statutory Auditor with an unmodified opinion and does not contain any qualifications, reservations or adverse remarks. Auditors Report are self-explanatory and do not call for any further comments.

During the year under review, the Auditors have not reported any fraud under Section 143(12) of the Act and therefore disclosure of details under Section 134(3)(ca) of the Act is not applicable.

Secretarial Auditor:

Pursuant to the provisions of Section 204 of the Act and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 and Regulation 24A of the SEBI Listing Regulations, M/s. Shivam Sharma & Associates, Practicing Company Secretaries (Certificate of Practice No. 16558), a peer reviewed firm of Company Secretaries in Practice, were appointed as Secretarial auditors of the Company for audit period of five consecutive years commencing from FY 2025-26 to FY 2029-30.

The Secretarial Audit Report in form MR-3 for FY 2025-26 is enclosed as "Annexure II" to this report. The Secretarial Audit Report does not contain any qualifications, reservations or adverse remarks. During the year under review, the Secretarial Auditor has not reported any fraud under Section 143(12) of the Act and therefore disclosure of details under Section 134(3)(ca) of the Act is not applicable.

ACCOUNTING TREATMENT

The accounting treatment is in line with the applicable Indian Accounting Standards (IND-AS) as recommended by the Institute of Chartered Accountants of India (ICAI) and prescribed by the General Government.

SECRETARIAL STANDARDS

During the year under review, the Company has complied with all the applicable provisions of Secretarial Standard - 1 and Secretarial Standard - 2 issued loans by the Institute of Company Secretaries of India and notified by the Ministry of Corporate Affairs.

CONTRACTS AND ARRANGEMENTS WITH RELATED PARTIES

All contracts/ arrangements/ transactions entered by the Company during FY 2025-26 with related parties were valued on an arms length basis and in the ordinary course of business and approved by the Audit Committee consisting of Independent Directors. Certain transactions, which were repetitive in nature, were approved through omnibus route.

Any Related Party Transaction (RPT) exceeding the thresholds prescribed under the SEBI Listing Regulations shall be considered material and would require prior approval of the Members. There were no material transactions of the Company with any of its related parties during the year in terms of Section 134 read with Section 188 of the Act. Therefore, the disclosure of the Related Party Transactions as required under Section 134(3)(h) of the Act in Form AOC-2 is not applicable to the Company for FY 2025-26 and, hence, the same is not required to be provided.

The details of RPTs during FY 2025-26, including transaction with person or entity belonging to the promoter/ promoter group which hold(s) 10% or more shareholding in the Company are provided in the accompanying financial statements. During FY 2025-26, the Non-Executive Directors of the Company had no pecuniary relationship or transactions with the Company other than sitting fees and reimbursement of expenses, as applicable. Pursuant to the requirements of the Act and the SEBI Listing Regulations, the Company has formulated a policy on RPTs and is available on Companys website URL at: https://www.hpadhesives.com/wp-content/uploads/2026/08/Related-party-Transactions-policy-and-dealing-with-related-party-transactions-amended_13.08.2026.pdf.

The attention of the members is drawn to note no. 41 of the financial statements setting out the disclosures on related party transactions for FY 2025-26.

Pursuant to Regulation 23(9) of the SEBI Listing Regulations, your Company has filed the reports on related party transactions with the Stock Exchanges within statutory timelines.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO

The information on conservation of energy, technology absorption and foreign exchange earnings and outgo stipulated under Section 134(3)(m) of the Act read with Rule 8 of the Companies (Accounts) Rules, 2014, is enclosed as "Annexure III" to this report.

RISK MANAGEMENT

The provision of Regulation 21(4) of SEBI Listing Regulations is not applicable to the Company. The Company, however, has adopted Risk Management policy, which can be accessed at https://www.hpadhesives.com/wp-content/uploads/2014/08/Risk-Assessment-and-Management-Policy.pdf

ANNUAL RETURN

Pursuant to Section 134(3)(a) of the Act, the Annual Return of the Company prepared as per Section 92(3) of the Act for the financial year ended 31st March, 2026, is uploaded on the website of the Company and the same is available on https://www.hpadhesives.com/investor-relations/.

SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS

During the year under review, there were no significant and material orders passed by the Regulators / Courts that would impact the going concern status of the Company and its future operations.

DETAILS OF APPLICATION MADE OR ANY PROCEEDING PENDING UNDER THE INSOLVENCY AND BANKRUPTCY CODE, 2016 DURING THE YEAR ALONG WITH THEIR STATUS AS AT THE END OF THE FINANCIAL YEAR

During the year under review and till date of this Report, the Company has neither made any application against anyone nor any proceedings were pending against the Company under the Insolvency and Bankruptcy Code, 2016.

CORPORATE SOCIAL RESPONSIBILITY (CSR)

In compliance with the provisions of Section 135 of the Act read with the Companies (Corporate Social Responsibility Policy) Rules, 2014, the Company has constituted a Corporate Social Responsibility (CSR) Committee. It is committed to ensure the social well-being of the communities through its CSR initiatives, in alignment with the Companys key priorities. The details of the Committee along with its terms of reference have been provided in the Corporate Governance Report.

The Company has adopted a Corporate Social Responsibility Policy in accordance with the Companies (Corporate Social Responsibility Policy) Rules, 2014 which can be accessed at https://www.hpadhesives.com/wp-content/uploads/2014/08/Corporate-Social-Responsibility-Policy.pdf.

The brief outline of the CSR Policy of the Company and the initiatives undertaken by the Company during the financial year ended 31st March, 2026, in accordance with Section 135 of the Act and Companies (Corporate Social Responsibility Policy) Rules, 2014 is set out in "Annexure IV" to this report.

INTERNAL FINANCIAL CONTROL

The Company has laid down internal financial control through entity level control inter-alia to ensure orderly and efficient conduct of business, including adherence to the Companys policies and procedures, accuracy and completeness of accounting records and timely preparation and reporting of reliable financial statements/information, safeguarding of assets, prevention and detection of frauds and errors.

The Board of Directors of the Company have adopted various policies like Related Party Transactions Policy, Whistle Blower Policy, Code of Conduct for regulating, monitoring and reporting Insider Trading and such other procedures for ensuring the orderly and efficient conduct of its business, prevention and detection of frauds and errors, accuracy and completeness of the accounting and timely preparation of financial information.

Based on the requirements under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Board has approved the Code of Conduct for Prohibition of Insider Trading and the same is being implemented by the Company.

VIGIL MECHANISM

In pursuance of the provisions of Section 177(9) & (10) of the Act and Regulation 22 of SEBI Listing Regulations, a vigil mechanism named "HP Adhesives Limited Whistle Blower Policy" for Directors and employees to report genuine concerns has been established. The policy on whistle mechanism can be accessed at https://www.hpadhesives.com/wp-content/uploads/2014/08/Vigil-Mechanism-Whistle-Blower-Policy.pdf.

The policy lays down a framework and process, which provides a platform to disclose information, confidentiality and without fear of reprisal or victimisation, where there is reason to believe that there has been serious malpractice, fraud, impropriety, abuse or wrongdoing, grievances about leakage of unpublished price sensitive information, illegal and unethical behaviour within the Company to the Vigilance Officer.

PARTICULARS OF LOANS, GUARANTEES AND INVESTMENTS

During the period under review, the Company has not provided any loans / guarantees or investments which come under the provisions of Section 186 of the Companies Act, 2013.

SHARE REGISTRAR & TRANSFER AGENT (R&T)

Bigshare Services Private Limited is the Registrar and Transfer Agent of the Company. They were appointed as the Registrar and Share Transfer Agent of the Company with effect from 7th July, 2021.

PREVENTION OF SEXUAL HARASSMENT OF WOMEN AT WORKPLACE POLICY

The Company has zero tolerance for sexual harassment at the workplace and has adopted a policy on prevention, prohibition and redressal of sexual harassment at workplace in line with the provisions of Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 and the rules framed thereunder. The Company has duly constituted an Internal Complaints Committee (ICC) as required under Sexual Harassment of Women at

Workplace (Prevention, Prohibition and Redressal) Act, 2013. During the year under review no complaint pertaining to sexual harassment at work place has been received by the Company.

PARTICULARS OF EMPLOYEES AND RELATED DISCLOSURES

The information required under Section 197(12) of the Act read with Rule 5 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 (including amendments thereto), is attached as "Annexure V" to this Report.

A Statement containing Particulars of Top 10 Employees and Particulars of Employees under Section 197(12) of the Act read with Rule 5(2) and (3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, forms part of this Report. The circulation of this Statement to the shareholders has been excluded in terms of proviso to Section 136(1) of the Act. None of the employees listed in the said Annexure are related to any Director of the Company.

EMPLOYEES STOCK OPTION SCHEME

The Company has adopted the HP ADHESIVES EMPLOYEES STOCK OPTION SCHEME - 2024 (the "ESOP 2024 Scheme") for a pool of 15,00,000 options. Further, the Company has not made any grants under the ESOP 2024 Scheme. A certificate pursuant to Regulation 13 of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 has been obtained from Shivam Sharma & Associates, Secretarial Auditors of the Company, and is annexed to this Report.

HUMAN RESOURCES

The Company considers its Human Resource (HR) as the key to achieve its objectives. HR Department create all strategies along with Senior Management and Board of Directors to attract talent and build capabilities. The employees are sufficiently empowered and enabled to work in an environment that inspires them to achieve higher levels of performance. The unflinching commitment of the employees is the driving force behind fulfilling the Company s vision. Your Company appreciates the contribution of its dedicated employees.

COMPLIANCE WITH THE MATERNITY BENEFIT ACT, 1961

The Company has complied with the provisions of the Maternity Benefit Act, 1961, including all applicable amendments and rules framed thereunder. The Company is committed to ensuring a safe, inclusive, and supportive workplace for women employees. All eligible women

employees are provided with maternity benefits as prescribed under the Maternity Benefit Act, 1961, including paid maternity leave, nursing breaks, and protection from dismissal during maternity leave.

GENERAL

Your directors state that no disclosure or reporting is required in respect of following items as there were no transactions on these items during the year under review:

a. Issue of equity shares with differential voting rights as to dividend, voting or otherwise;

b. Issue of shares (including sweat equity shares) to employees of the Company under any scheme;

c. No frauds were reported by the Auditors during the year under review;

d. Maintenance of Cost Records as specified by the Central Government under Section 148(1) of the Companies Act, 2013 is not required by the Company.

cc

u

e. There are no proceedings pending under the Insolvency and Bankruptcy Code, 2016.

5

f. There are no instances of one-time settlement with any Bank or Financial Institution.

CAUTIONARY STATEMENT

Statements in the Board s Report and the Management Discussion & Analysis Report describing the Company s objectives, expectations or forecasts may be forward-looking within the meaning of applicable laws and regulations. Actual results may differ from those expressed in the statements.

ACKNOWLEDGEMENTS

Your Directors express their gratitude to the members, bankers, customers, regulatory and statutory authorities, and other business stakeholders for their valuable support and co-operation.

Your directors also thank the employees of the Company for their continued contribution, commitment and dedication.

For and on behalf of the Board of Directors For HP Adhesives Limited
Place: Mumbai Date: 13th August, 2026 Mrs. Anjana Haresh Motwani Chairperson & Executive Director DIN:02650184 Mr. Karan Haresh Motwani Managing Director DIN:02650089

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited. All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.